Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy
NCT ID: NCT05153629
Last Updated: 2024-10-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2021-01-10
2023-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones
NCT02028559
Sterile Water Injections for Relieving Ureterolithiasis Pain
NCT01412840
Ureteral Stent Length and Patient Symptoms
NCT00288457
An Intelligent Pressure and Temperature Control Ureteral Soft Scope System for Treating Stones With Infection.
NCT06841523
Ultrasound Imaging of Kidney Stones and Lithotripsy
NCT02214836
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard care
Participants will follow standard care until the ureteral stent is removed
No interventions assigned to this group
TENS device
Participants will use the TENS device until the ureteral stent is removed
TENS
TENS device used four times a day for 60 minutes each time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TENS
TENS device used four times a day for 60 minutes each time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients receiving a stent following their ureteroscopy and laser lithotripsy
Exclusion Criteria
* Pregnant patients
* Patients unable to answer pain questionnaire
* Patients undergoing PCNL
* Patients being treated for Urologic malignancy with ureteroscopy
* Patients who require long term or chronic ureteral stent management
* Patient with implantable stimulators
* Patient with epilepsy
* Patients undergoing laser lithotripsy without stent placement
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simon Conti
Clinical Assistant Professor, Urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon Conti, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-62416
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.